Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nontoxic MMP inhibitor from Pharmacia with antitumor activity

July 16, 2001

Exelixis delivers cancer antibody targets to PDL for further development

July 16, 2001

Neutrophil elastase inhibitor prevents cancer metastasis in animal model

July 16, 2001

Idec submits additional information for Zevalin BLA

July 16, 2001

New Photofrin indication filed with Canadian authorities

July 16, 2001

Tie2 receptor kinase inhibitors useful for angiogenic disorders

July 13, 2001

EntreMed begins enrollment of initial patients in phase I/II study of rhEndostatin

July 13, 2001

Use of PRAC protein in cancer Rx available for licensing from NIH

July 13, 2001

Promising phase III trial results reported with Leuprogel three-month depot

July 11, 2001

Aventis transfers selected product rights to Introgen Therapeutics through investment

July 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...